TLR4 is expressed on various immune cells, including DCs, macrophages, and NK cells, as well as on HCC cells, activating several pathways such as NF-κB, MAPK, and phosphoinositide 3-kinase (PI3K)/Akt. This evidence concerns the gene NFKB1 and hepatocellular carcinoma.